Why is Rossari Biotech falling/rising?

As of 08-Oct, Rossari Biotech Ltd's stock price is currently at 660.00, reflecting an increase of 31.6 or 5.03%. The stock has shown a positive trend today, having outperformed its sector by 5.87% and reversing a two-day decline. It reached an intraday high of Rs 685, indicating strong intraday performance despite trading in a wide range of Rs 62.95. Over the past week, the stock has gained 3.73%, while its one-month return stands at 7.14%. However, it is important to note that the stock has experienced a significant decline over the longer term, with a year-to-date return of -16.21% and a one-year return of -22.26%. The company maintains a low debt-to-equity ratio of 0.03, a return on equity of 11.5, and high institutional holdings at 21.32%, which may contribute to its perceived stability and attractiveness despite recent profit declines.
In the broader market context, Rossari Biotech's short-term performance has significantly outpaced the Sensex, which has only increased by 0.98% over the past week and 1.22% over the past month. This suggests that while the stock is currently experiencing a positive movement, it has underperformed the benchmark over the longer term, as evidenced by its year-to-date decline compared to the Sensex's gain of 4.65%. The falling investor participation, indicated by a 56.28% drop in delivery volume, may raise concerns about the stock's liquidity and future performance, despite its current upward movement.